Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib studyKamran A. Ahmed, Hyo S. Han, Aixa Soyano et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 7